Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients

NCT06682156 · clinicaltrials.gov ↗

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed Multiple Myeloma

Interventions

DRUG: Carfilzomib

Sponsor

The First Affiliated Hospital of Soochow University